AMPlify – Accelerated US Market Entry for Finnish Healthcare Companies

AMPlify is an established platform designed to advance Finnish healthcare companies’ US market readiness and entry. Expanding upon the successful Nordic AMPlify and Gazelle programs, AMPlify is a complete ecosystem that brings Finnish companies and Mayo Clinic together.
With the US accounting for 40% of the global healthcare market and over 30% of new technologies emerging from collaborations with international partners, American health systems are evolving their innovation hubs into global co-development initiatives. AMPlify is leading this transition, and Mayo Clinic has picked Finland as a strategy focus area.
Mayo Clinic, one of the leading health systems globally, constantly seeks to provide its patients the best and most efficient care. They recognize that this can only be accomplished through constant innovation across the entire continuum of care. Hence, there is a need to find the best ways to improve care, reduce costs, and improve the quality of life for all patients.
Collaboration is essential, and working with emerging companies and fresh ideas has proven to be an effective strategy. The need for more and better digital tools is real and visible. Now is the time to focus resources on US entry through AMPlify with local champions. AMPlify is a strategic and competitive advantage.
AMP is a carefully thought-out and curated program consisting of workshops, one-on-one mentoring, and webinars with leading US healthcare players, including providers, VCs, strategics, and Mayo Clinic experts. Participating companies gain valuable insights, refine their value propositions, and receive guidance from KOLs, all while deepening their understanding of the US market and business landscape. Every aspect of commercial and clinical success is addressed through the program.
The application period is open from March 11th to April 20th, 2025. AMPlify 2025 will accommodate 10–12 selected companies, offering a structured pathway to accelerate U.S. market entry.
- Virtual program introduction: March 11, 2025
- Application Period: March 11 – April 20, 2025 (All applications must be submitted by April 20, 2025)
- Cohort Selection: Announced in June 2025
- Mentoring Sessions: Begin following cohort selection
- In-Person Kickoff: Helsinki, August 2025
- One-on-One mentoring: Each company will receive two individual mentoring sessions (60–90 minutes each)
- Workshops & Webinars: Virtual bi-weekly sessions from September to October 2025
- U.S. Market Visit: On-site visit to Mayo Clinic, Rochester, Minnesota, in November 2025
- Participation Fee: EUR 6,000 (travel expenses to Rochester not included)
- Eligible companies can apply for Business Finland funding, or the costs may be included in the ongoing DTA/NIY project. Discuss this with your BF contact.
Contact persons:
Titta Houni
Senior Advisor
New York, USA
titta.houni@businessfinland.fi
Renne Kaseva
Senior Advisor
Helsinki
renne.kaseva@businessfinland.fi